SPDR S&P Biotech ETF Shares Down 23.2% Since SmarTrend's Sell Call (XBI)
February 02, 2016 at 15:16 PM EST
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on January 6th, 2016 at $64.83. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 23.16% as of...
